MSB 2.51% 97.0¢ mesoblast limited

MSB Trading - 2020, page-266

  1. 315 Posts.
    lightbulb Created with Sketch. 346
    A so-so CHF trial result would be terribly disappointing. And I agree the SP would get smashed.

    But with the FDA decision hot on its heels and almost certainly good news (and in turn a profitable company).
    I will be ready to take advantage of the last dirt cheap SP.

    Long term it will still be a good buy.
    Maybe just not to the statospheric levels we are hoping for. Or at least not so quickly.

    But don't forget. 800 patents 69 patent families ...and counting.
    CHF is important. But it won't make or break the company imo.


  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.